Comparative activity in vitro of ceftazidime and nine other antibacterial agents

Development of a novel assay method for colistin sulphomethate.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2005

An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

The Journal of antimicrobial chemotherapy·2004

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials.

The Journal of antimicrobial chemotherapy·2002

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

The Journal of antimicrobial chemotherapy·2001

Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.

Antimicrobial agents and chemotherapy·2001

Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin.

The Journal of antimicrobial chemotherapy·2000

Cefepime/enmetazobactam for invasive infections caused by extended-spectrum beta-lactamase-producing Enterobacterales: a real-world case series.

Infection·2026

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

Infection·2026

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Infection·2026

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Infection·2026

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Infection·2026

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Infection·2026

Antibacterial and antibiofilm activities of pyocins produced by Pseudomonas aeruginosa against gram-negative bacteria: a systematic review (2015-2025).

Frontiers in microbiology·2026

Clinical outcomes of residual branch vessel dissection following type A aortic dissection repair.

Frontiers in medicine·2026

Fabrication of aptamer-mediated Fe₃O₄@AuNPs magnetic capture and Ag-enhanced SERS nanoplatforms for bacterial detection.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

Whole-genome sequences of Pseudomonas aeruginosa strains isolated from patients and inanimate hospital reservoirs in Chattogram, Bangladesh.

Microbiology resource announcements·2026

Benchmarking four commercial antimicrobial susceptibility testing systems and disk diffusion to reference broth microdilution in the assessment of gram-negative bacterial isolates.

Journal of clinical microbiology·2026

Targeting DNA gyrase B: medicinal chemistry strategies to combat antimicrobial resistance.

RSC medicinal chemistry·2026

Related Experiment Videos

Comparative activity in vitro of ceftazidime and nine other antibacterial agents

Related Concept Videos

Development of a novel assay method for colistin sulphomethate.

An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials.

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.

Assessment of different antibacterial effect measures used in in vitro models of infection and subsequent use in pharmacodynamic correlations for moxifloxacin.

Cefepime/enmetazobactam for invasive infections caused by extended-spectrum beta-lactamase-producing Enterobacterales: a real-world case series.

Persistent candidemia matters: risk factors and clinical outcomes in a retrospective matched cohort study.

A retrospective study of alternative antibiotics for prophylaxis of the Group B Streptococcus maternal-fetal disease.

Outcomes and associated risk factors among hospitalisations attributed to invasive group A streptococcal disease in Northern Queensland, Australia: a 21-year population-based data linkage study.

Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry.

Clinical utility of time to positivity in candidemia: prognostic limitations and species-specific implications.

Antibacterial and antibiofilm activities of pyocins produced by Pseudomonas aeruginosa against gram-negative bacteria: a systematic review (2015-2025).

Clinical outcomes of residual branch vessel dissection following type A aortic dissection repair.

Fabrication of aptamer-mediated Fe₃O₄@AuNPs magnetic capture and Ag-enhanced SERS nanoplatforms for bacterial detection.

Whole-genome sequences of Pseudomonas aeruginosa strains isolated from patients and inanimate hospital reservoirs in Chattogram, Bangladesh.

Benchmarking four commercial antimicrobial susceptibility testing systems and disk diffusion to reference broth microdilution in the assessment of gram-negative bacterial isolates.

Targeting DNA gyrase B: medicinal chemistry strategies to combat antimicrobial resistance.

Related Experiment Videos

Comparative activity in vitro of ceftazidime and nine other antibacterial agents

Related Concept Videos

Related Articles